HomeInsightsMarket Capitalization

Market Capitalization of Zydus Lifesciences Ltd

Market Capitalization of Zydus Lifesciences Ltd

stocks purchased

₹ 0.4 Cr

Volume Transacted

(Nov 8, 2024)

stocks purchased

4.4 K

Stocks Traded

(Nov 8, 2024)

Last Updated on: Nov 08, 2024

Image

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE

MARKETCAP

₹ 97866.32 crore

Last updated on: Nov 07, 2024

Key Highlights

  • The Market Cap of Zydus Lifesciences Ltd is ₹ 97866 crore as of 07 Nov 24.
  • The Market Cap of Zydus Lifesciences Ltd changed from ₹ 35482 crore on March 2019 to ₹ 101151 crore on March 2024 . This represents a CAGR of 19.08% over 6 years. .
  • The Latest Trading Price of Zydus Lifesciences Ltd is ₹ 969.75 as of 08 Nov 09:22.
  • The Dividend Payouts of Zydus Lifesciences Ltd changed from ₹ 3.5 on Jul 25, 2019 to ₹ 3 on Jul 26, 2024 . This represents a CAGR of -2.54% over 6 years. .

Historical Market Cap of Zydus Lifesciences Ltd

No data available

* All values are in crore

Company Fundamentals for Zydus Lifesciences Ltd

No data available

Image

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE

PRICE

₹ 969.75

-2.85 (-0.29%)

stock direction

Last updated on: Nov 08 09:22 AM

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Zydus Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 2024972.6
06 Nov 2024995
05 Nov 2024989.3
04 Nov 20241004.3
01 Nov 20241004
31 Oct 20241001.85
30 Oct 2024985.55
29 Oct 20241002.3
28 Oct 20241006.65
25 Oct 2024990.2

SWOT Analysis Of Zydus Lifesciences Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

2

T

BlinkX Score for Zydus Lifesciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Zydus Lifesciences Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Zydus Lifesciences Ltd

No data available

No data available

Historical P/E Ratio of Zydus Lifesciences Ltd

No data available

* All values are in %

Historical Revenue of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical EBITDA of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical Net Profit of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Zydus Lifesciences Ltd

No data available

* All values are in

About Zydus Lifesciences Ltd

  • Zydus Lifesciences Ltd. (Formerly known as Cadila Healthcare Ltd.) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), Active Pharmaceutical Ingredients (APIs), animal healthcare products and consumer wellness products. The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and Solan in Himachal Pradesh. Founded by the Late Promoter, Mr. Ramanbhai B. Patel, the Company was incorporated in May, 1995 and converted into a Public Limited Company in July, 1996.

Zydus Lifesciences Ltd News Hub

News

Zydus Lifesciences to table results

Zydus Lifesciences will hold a meeting of the Board of Directors of the Company on 12 Nove...

Read more

31 Oct 202411:58

News

Zydus Life rises on in-principle approval from WHO for typhoid vaccine

ZyVac TCV is now eligible for purchase by United Nations (UN) agencies. It is indigenously...

Read more

23 Oct 202414:50

News

Zydus receives USFDA approval for Fludrocortisone Acetate Tablets

Zydus Lifesciences has received final approval from the United States Food and Drug Admini...

Read more

18 Oct 202409:29

News

Zydus Life gets final approval from USFDA for Fludrocortisone Acetate tab

Fludrocortisone Acetate tablets are indicated as partial replacement therapy for primary a...

Read more

18 Oct 202412:47

News

Zydus partners with ICMR to initiate Phase 2 clinical trials of Desidustat oral tablet for treating sickle cell disease

Zydus Lifesciences has formalized the Memorandum of Agreement (MoA) with Indian Council of...

Read more

15 Oct 202410:08

News

Zydus Life gets final approval from USFDA for Paliperidone drug

Paliperidone extended-release tablets are indicated for the acute and maintenance treatmen...

Read more

10 Oct 202414:51

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Zydus Lifesciences Ltd Market Cap

What is the market cap of Zydus Lifesciences Ltd?

As of November 8, 2024, Zydus Lifesciences Ltd has a market capitalization of ₹97866.32, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Zydus Lifesciences Ltd's market capitalization?

Zydus Lifesciences Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Zydus Lifesciences Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Zydus Lifesciences Ltd's market capitalization change?

Zydus Lifesciences Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*